Hirschfield GM - Search Results

1

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. Danesh J, et al. Among authors: hirschfield gm. N Engl J Med. 2004 Apr 1;350(14):1387-97. doi: 10.1056/NEJMoa032804. N Engl J Med. 2004. PMID: 15070788 Free article.

2

C-reactive protein and atherothrombosis.

Pepys MB, Hirschfield GM. Pepys MB, et al. Among authors: hirschfield gm. Ital Heart J. 2001 Mar;2(3):196-9. Ital Heart J. 2001. PMID: 11305531 Review.

3

C-reactive protein and its role in the pathogenesis of myocardial infarction.

Pepys MB, Hirschfield GM. Pepys MB, et al. Among authors: hirschfield gm. Ital Heart J. 2001 Nov;2(11):804-6. Ital Heart J. 2001. PMID: 11770862

4

C-reactive protein: a critical update.

Pepys MB, Hirschfield GM. Pepys MB, et al. Among authors: hirschfield gm. J Clin Invest. 2003 Jun;111(12):1805-12. doi: 10.1172/JCI18921. J Clin Invest. 2003. PMID: 12813013 Free PMC article. Review. No abstract available.

5

C-reactive protein and cardiovascular disease: new insights from an old molecule.

Hirschfield GM, Pepys MB. Hirschfield GM, et al. QJM. 2003 Nov;96(11):793-807. doi: 10.1093/qjmed/hcg134. QJM. 2003. PMID: 14566035 Review.

6

Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice.

Hirschfield GM, Herbert J, Kahan MC, Pepys MB. Hirschfield GM, et al. J Immunol. 2003 Dec 1;171(11):6046-51. doi: 10.4049/jimmunol.171.11.6046. J Immunol. 2003. PMID: 14634117

7

Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting.

Gomma AH, Hirschfield GM, Gallimore JR Jr, Lowe GD, Pepys MB, Fox KM. Gomma AH, et al. Among authors: hirschfield gm. Am Heart J. 2004 Jun;147(6):1071-7. doi: 10.1016/j.ahj.2003.10.050. Am Heart J. 2004. PMID: 15199358 Clinical Trial.

8

Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability.

Clapp BR, Hirschfield GM, Storry C, Gallimore JR, Stidwill RP, Singer M, Deanfield JE, MacAllister RJ, Pepys MB, Vallance P, Hingorani AD. Clapp BR, et al. Among authors: hirschfield gm. Circulation. 2005 Mar 29;111(12):1530-6. doi: 10.1161/01.CIR.0000159336.31613.31. Circulation. 2005. PMID: 15795363

9

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

Hirschfield GM, Gallimore JR, Kahan MC, Hutchinson WL, Sabin CA, Benson GM, Dhillon AP, Tennent GA, Pepys MB. Hirschfield GM, et al. Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8309-14. doi: 10.1073/pnas.0503202102. Epub 2005 May 26. Proc Natl Acad Sci U S A. 2005. PMID: 15919817 Free PMC article.

10

Targeting C-reactive protein for the treatment of cardiovascular disease.

Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, Hawkins PN, Myers RM, Smith MD, Polara A, Cobb AJ, Ley SV, Aquilina JA, Robinson CV, Sharif I, Gray GA, Sabin CA, Jenvey MC, Kolstoe SE, Thompson D, Wood SP. Pepys MB, et al. Among authors: hirschfield gm. Nature. 2006 Apr 27;440(7088):1217-21. doi: 10.1038/nature04672. Nature. 2006. PMID: 16642000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters